Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Where PTSC should be trading....

Where PTSC should be trading....

posted on Apr 20, 2007 01:59PM

Third Q net income = $9.6 mil

Annualized net income ($9.6 x 4) = $38.4 mil.

Total shares OS = 378,668,118

EPS = 0.1014/share

Reasonable/conservative PE of 15

EPS x 15 = $1.52/share

 

Even allowing for some uncertainty re: Markman, and normal OTC-BB manipulation and shenanigans, PTSC should be over a buck RIGHT NOW!

MHO and good luck to the longs!

Share
New Message
Please login to post a reply